AgomAb Therapeutics (AGMB) stock: insider trades, news & valuation
Health Care · Strong buyingShare price and insider trades
AgomAb Therapeutics insider trading at a glance (Oct 9, 2026): in the past 12 months, 3 insiders bought $311K and 0 sold $0 of AGMB stock on the open market, including a cluster buy that began Oct 5, 2026.
Get emailed when insiders cluster-buy stocks like AGMB
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
AGMB insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | $311K | 8 | — | 0 |
Valuation, profit and volume
Pick score 57/100Summary
Over the past 12 months, 3 AgomAb Therapeutics NV insiders reported open-market purchases totaling $311K, while 0 insiders reported sales totaling $0. The most recent cluster buy began on Oct 5, 2026, when 3 insiders bought a combined $311K.
AGMB news sentiment trend
Weekly headline tone (positive minus negative headlines) over 13 weeks. Green dots mark weeks with insider buying.
Tone is scored from headline wording only. It describes the news, not where the stock is going.
AGMB stock news and SEC filings
Recent 8-K filings and headlines. Tone is scored from the headline wording; “Policy” marks regulatory, trade or government topics.
- News Analyzing Lucid Diagnostics ( NASDAQ : LUCD ) and argenex ( NASDAQ : ARGX ) · dailypolitical.com
- News Comparing Capricor Therapeutics ( NASDAQ : CAPR ) & argenex ( NASDAQ : ARGX ) · tickerreport.com
- News AgomAb Therapeutics ( NASDAQ : AGMB ) Shares Down 6 . 3 % – Here What Happened · themarketsdaily.com
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Oct 9 NewSEC | David R EpsteinDirector | Buy | 5,00015,000 held (+50%) | $8.90 | $44K | +2.0% | — |
| Oct 7SEC | Tim Jasper KnotnerusCEO | Buy | 6,00016,823 held (+55%) | $8.48 | $51K | +7.1% | — |
| Oct 7SEC | David R EpsteinDirector | Buy | 5,00010,000 held (+100%) | $8.70 | $44K | +4.4% | — |
| Oct 7SEC | Tim Jasper KnotnerusCEO | Buy | 5,00021,823 held (+30%) | $8.70 | $44K | +4.4% | — |
| Oct 7SEC | David R EpsteinDirector | Buy | 5,000new position | $8.57 | $43K | +6.0% | — |
| Oct 7SEC | Pierre Thadee Victor KemulaCFO | Buy | 5,0008,000 held (+167%) | $8.57 | $43K | +6.0% | — |
| Oct 7SEC | Pierre Thadee Victor KemulaCFO | Buy | 3,000new position | $8.67 | $26K | +4.7% | — |
| Oct 7SEC | Pierre Thadee Victor KemulaCFO | Buy | 2,00010,000 held (+25%) | $8.54 | $17K | +6.3% | — |
Insiders at AgomAb Therapeutics NV
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| David R EpsteinDirector | $131K | — | Oct 9, 2026 | — |
| Tim Jasper KnotnerusCEO | $94K | — | Oct 7, 2026 | — |
| Pierre Thadee Victor KemulaCFO | $86K | — | Oct 7, 2026 | — |
Insider activity at other Health Care companies
Same sector, ranked by insider buying in the last 90 days.
AGMB stock: common questions
Are AgomAb Therapeutics NV insiders buying AGMB stock?
In the past 12 months, 3 insiders reported open-market purchases of AGMB worth $311K. The latest was Director David R Epstein bought $44K of AGMB at $8.90 — raises the stake by 50%.
Are AgomAb Therapeutics NV insiders selling AGMB stock?
0 insiders reported sales worth $0 over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is AGMB's 52-week range?
Over the past year AGMB has traded between $8.56 and $17.82. It last closed at $9.08 on Oct 9, 2026.